Alnylam to webcast conference call discussing fourth quarter and full year 2024 financial results

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that it will report financial results for the fourth quarter and year ending december 31, 2024 on thursday, february 13, 2025, before the u.s. financial markets open. management will provide an update on the company and discuss fourth quarter and year-end 2024 results as well as expectations for the future via conference call on thursday, february 13, 2025 at 8.
ALNY Ratings Summary
ALNY Quant Ranking